Precious Metals

[gfp927z]

Johnson & Johnson - >>> A Dividend King that won't let you down


https://www.fool.com/investing/2020/10/24/5-great-stocks-you-can-buy-and-hold-forever/


Johnson & Johnson (NYSE:JNJ) shares have done marvelously for long-term investors over the years.

Its clout in the consumer and healthcare sectors, a solid portfolio, brand power, impressive research and development, and an incredible dividend track record are just some of the things that have powered this company's returns upward. While the consumer side of the business -- which includes household names like Band-Aid, Neutrogena, and Listerine -- is a consistent cash-flow generator, Johnson & Johnson consistently scouts for growth in healthcare. That's exemplified by its latest acquisition -- autoimmune disease-drug specialist Momenta Pharmaceuticals, for which it paid $6.5 billion in cash. In 2019, Johnson & Johnson generated half its revenues from pharmaceuticals and one-third from medical devices.

Can Johnson & Johnson still build wealth for new investors? Sure it can, if you hang on to the stock. The company continues to prioritize R&D spending and has a humongous biotech pipeline. While these stories play out, you can collect rising dividend payouts year after year: Johnson & Johnson is a Dividend King, having boosted its payouts annually for 58 straight years. Shareholders can reinvest those dividends, then just sit back and watch their money grow.

<<<